Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

CME Eligible Sessions:

Availability:

Showing session: reset

Three Battles - One Stage: TB, Hepatitis, and Hepatocellular Cancer

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 11 of 11
Efficacy and Safety of BLV 2 or 10 mg in CHD Including Patients With HIV/HBV: MYR301 Final Results   (ABSTRACT 141)
David Wyles
Denver Health Medical Center, Denver, CO, USA
from CROI 2026 on February 24, 2026 10:00 AM-12:00 PM
Hepatitis B Reactivation/Infection in People With HIV on Tenofovir-Sparing Antiretroviral Therapy   (ABSTRACT 142)
Grace Haser
University of California San Francisco, San Francisco, CA, USA
from CROI 2026 on February 24, 2026 10:00 AM-12:00 PM
Long-Term Outcomes of Liver Transplant Recipients Living With HIV: A Multicenter Case-Control Study   (ABSTRACT 143)
José M. Miró
Hospital Clinic of Barcelona, Barcelona, Spain
from CROI 2026 on February 24, 2026 10:00 AM-12:00 PM
Early Detection of HCC via Active Surveillance in Persons With HIV in Uganda at High Risk   (ABSTRACT 144)
Katuku Jim Aizire
The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
from CROI 2026 on February 24, 2026 10:00 AM-12:00 PM
Questions and Answers (Part 1)
from CROI 2026 on February 24, 2026 10:00 AM-12:00 PM
One-Month Versus 3-Month Rifapentine-Based Tuberculosis Preventive Therapy in People With HIV   (ABSTRACT 145)
Anchalee Avihingsanon
Thai Red Cross AIDS Research Centre, Bangkok, Thailand
from CROI 2026 on February 24, 2026 10:00 AM-12:00 PM
Twice-Daily Dolutegravir With a 4-Month Rifapentine-Based Regimen for HIV-Associated Tuberculosis   (ABSTRACT 146)
Sean Wasserman
St George's University of London, London, UK
from CROI 2026 on February 24, 2026 10:00 AM-12:00 PM
DOLPHIN-Moms: Pharmacokinetics and HIV Suppression With Once-Daily Dolutegravir and 3HP in Pregnancy   (ABSTRACT 147)
Jyoti S. Mathad
Weill Cornell Medicine, New York, NY, USA
from CROI 2026 on February 24, 2026 10:00 AM-12:00 PM
Safety and Treatment Completion of 1HP Versus 3HP in People With HIV: The One-to-Three Trial   (ABSTRACT 148)
Jayajothi Moodley
The Aurum Institute, Johannesburg, South Africa
from CROI 2026 on February 24, 2026 10:00 AM-12:00 PM
Novel Linezolid Dosing With Bedaquiline, Delamanid, and Clofazimine for Drug-Resistant TB Treatment   (ABSTRACT 149)
Constance A. Benson
University of California San Diego, La Jolla, CA, USA
from CROI 2026 on February 24, 2026 10:00 AM-12:00 PM
Questions and Answers (Part 2)
from CROI 2026 on February 24, 2026 10:00 AM-12:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 11 of 11